BIRMINGHAM, Ala. (WBRC) – A recalled sickle cell drug is drawing new scrutiny from attorneys who say it may have done more harm than good, possibly even costing lives.
The drug, Oxbryta, was once promoted as a promising treatment for sickle cell disease. But after being voluntarily pulled from the market by pharmaceutical giant Pfizer last year, legal advocates say it’s time for the public to understand what may have gone wrong.
For Birmingham attorney Starr Culpepper-Jackson, the fight is deeply personal. Her daughter lives with sickle cell disease, and Culpepper-Jackson is now channeling that experience into a legal mission to hold Pfizer accountable…